Evaluation of the metS and murB loci for antibiotic discovery using targeted antisense RNA expression analysis in Bacillus anthracis

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 5, 2007, Pages 1708-1718

  Kedar, G C ^a   Brown Driver, Vickie ^a   Reyes, Daniel R ^a   Hilgers, Mark T ^a   Stidham, Mark A ^a   Shaw, Karen Joy ^a   Finn, John ^a   Haselbeck, Robert J ^a  

^a Trius Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; COMPLEMENTARY RNA; FOSFOMYCIN; MESSENGER RNA; METHIONINE TRANSFER RNA LIGASE; OXIDOREDUCTASE; UDP N ACETYLENOLPYRUVOYLGLUCOSAMINE REDUCTASE; UNCLASSIFIED DRUG;

ALLELE; ANTHRAX; ANTISENSE THERAPY; ARTICLE; ATTENUATION; BACILLUS ANTHRACIS; BACTERIAL GROWTH; CELL WALL; CONTROLLED STUDY; DNA REPLICATION; DRUG MECHANISM; DRUG POTENTIATION; EMPIRICISM; EVALUATION; FATTY ACID SYNTHESIS; GENE EXPRESSION; GENE INSERTION; GENE LOCUS; GENE REPLACEMENT THERAPY; GENE TARGETING; GENETIC TRAIT; HYPERSENSITIVITY; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; RNA TRANSCRIPTION; TRANSLATION INITIATION; VEGETATIVE GROWTH;

ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BASE SEQUENCE; CARBOHYDRATE DEHYDROGENASES; METHIONINE-TRNA LIGASE; MOLECULAR SEQUENCE DATA; RNA, ANTISENSE;

EID: 34248340854     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01180-06     Document Type: Article

References (71)

1. Altboum, Z., Y. Gozes, A. Barnea, A. Pass, M. White, and D. Kobiler. 2002. Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs. Infect. Immun. 70:6231-6241.
2. Anand, S. P., P. Mitra, A. Naqvi, and S. A. Khan. 2004. Bacillus anthracis and Bacillus cereus PcrA helicases can support DNA unwinding and in vitro rolling-circle replication of plasmid pT181 of Staphylococcus aureus. J. Bacteriol. 186:2195-2199.
3. Athamna, A., M. Athamna, N. Abu-Rashed, B. Medlej, D. J. Bast, and E. Rubinstein. 2004. Selection of Bacillus anthracis isolates resistant to antibiotics. J. Antimicrob. Chemother. 54:424-428.
4. Baillie, L. W. 2005. Bacillus anthracis, a story of nature subverted by man. Lett. Appl. Microbiol. 41:227-229.
5. Bakici, M. Z., N. Elaldi, M. Bakir, I. Dokmetas, M. Erandac, and M. Turan. 2002. Antimicrobial susceptibility of Bacillus anthracis in an endemic area. Scand. J. Infect. Dis. 34:564-566.
6. Barrow, E. W., P. C. Bourne, and W. W. Barrow. 2004. Functional cloning of Bacillus anthracis dihydrofolate reductase and confirmation of natural resistance to trimethoprim. Antimicrob. Agents Chemother. 48:4643-4649.
7. Bhavsar, A. P., X. Zhao, and E. D. Brown. 2001. Development and characterization of a xylose-dependent system for expression of cloned genes in Bacillus subtilis: conditional complementation of a teichoic acid mutant. Appl. Environ. Microbiol. 67:403-410.
8. Bronson, J. J., K. L. DenBleyker, P. J. Falk, R. A. Mate, H. T. Ho, M. J. Pucci, and L. B. Snyder. 2003. Discovery of the first antibacterial small molecule inhibitors of MurB. Bioorg. Med. Chem. Lett. 13:873-875.
9. Brouillard, J. E., C. M. Terriff, A. Tofan, and M. W. Garrison. 2006. Antibiotic selection and resistance issues with fluoroquinolones and doxycycline against bioterrorism agents. Pharmacotherapy 26:3-14.
10. Brown, J. R., D. Gentry, J. A. Becker, K. Ingraham, D. J. Holmes, and M. J. Stanhope. 2003. Horizontal transfer of drug-resistant aminoacyl-transfer-RNA synthetases of anthrax and gram-positive pathogens. EMBO Rep. 4:692-698.
11. Bryskier, A. 2005. Antimicrobial agents: antibacterials, and antifungals, 1st ed., p. 1183-1238. ASM Press, Washington, D.C.
12. Critchley, I. A., C. L. Young, K. C. Stone, U. A. Ochsner, J. Guiles, T. Tarasow, and N. Janjic. 2005. Antibacterial activity of REP8839, a new antibiotic for topical use. Antimicrob. Agents Chemother. 49:4247-4252.
13. Daniel, R. A., and J. Errington. 1993. DNA sequence of the murE-murD region of Bacillus subtilis 168. J. Gen. Microbiol. 139:361-370.
14. Desai, R. P., and E. T. Papoutsakis. 1999. Antisense RNA strategies for metabolic engineering of Clostridium acetobutylicum. Appl. Environ. Microbiol. 65:936-945.
15. Deziel, M. R., H. Heine, A. Louie, M. Kao, W. R. Byrne, J. Basset, L. Miller, K. Bush, M. Kelly, and G. L. Drusano. 2005. Effective antimicrobial regimens for use in humans for therapy of Bacillus anthracis infections and postexposure prophylaxis. Antimicrob. Agents Chemother. 49:5099-5106.
16. Diederich, L., A. Roth, and W. Messer. 1994. A versatile plasmid vector system for the regulated expression of genes in Escherichia coli. BioTechniques 16:916-923.
17. Dunny, G. M., L. N. Lee, and D. J. LeBlanc. 1991. Improved electroporation and cloning vector system for gram-positive bacteria. Appl. Environ. Microbiol. 57:1194-1201.
18. El Zoeiby, A., F. Sanschagrin, and R. C. Levesque. 2003. Structure and function of the Mur enzymes: development of novel inhibitors. Mol. Microbiol. 47:1-12.
19. Finn, J., J. Hill, S. Ram, et al. 2001. Novel antibacterial agents targeting methionyl-tRNA synthetase: a cheminformatic approach to convert HTS data to quality medicinal chemistry leads, abstr. F-2140. 41st Int. Conf. Antimicrob. Agents Chemother., Chicago, IL. American Society for Microbiology, Washington, DC.
20. Forsyth, R. A., R. J. Haselbeck, K. L. Ohlsen, R. T. Yamamoto, H. Xu, J. D. Trawick, D. Wall, L. Wang, V. Brown-Driver, J. M. Froelich, K. G. C., P. King, M. McCarthy, C. Malone, B. Misiner, D. Robbins, Z. Tan, Z. Y. Zhu Zy, G. Carr, D. A. Mosca, C. Zamudio, J. G. Foulkes, and J. W. Zyskind. 2002. A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol. Microbiol. 43:1387-1400.
21. Francisco, G. D., Z. Li, J. D. Albright, N. H. Eudy, A. H. Katz, P. J. Petersen, P. Labthavikul, G. Singh, Y. Yang, B. A. Rasmussen, Y. I. Lin, and T. S. Mansour. 2004. Phenyl thiazolyl urea and carbamate derivatives as new inhibitors of bacterial cell-wall biosynthesis. Bioorg. Med. Chem. Lett. 14: 235-238.
22. Gardete, S., A. M. Ludovice, R. G. Sobral, S. R. Filipe, H. de Lencastre, and A. Tomasz. 2004. Role of murE in the expression of β-lactam antibiotic resistance in Staphylococcus aureus. J. Bacteriol. 186:1705-1713.
23. Gartner, D., J. Degenkolb, J. A. Ripperger, R. Allmansberger, and W. Hillen. 1992. Regulation of the Bacillus subtilis W23 xylose utilization operon: interaction of the Xyl repressor with the xyl operator and the inducer xylose. Mol. Gen. Genet. 232:415-122.
24. Gartner, D., M. Geissendorfer, and W. Hillen. 1988. Expression of the Bacillus subtilis xyl operon is repressed at the level of transcription and is induced by xylose. J. Bacteriol. 170:3102-3109.
25. Gentry, D. R., K. A. Ingraham, M. J. Stanhope, S. Rittenhouse, R. L. Jarvest, P. J. O'Hanlon, J. R. Brown, and D. J. Holmes. 2003. Variable sensitivity to bacterial methionyl-tRNA synthetase inhibitors reveals subpopulations of Streptococcus pneumoniae with two distinct methionyl-tRNA synthetase genes. Antimicrob. Agents Chemother. 47:1784-1789.
26. Grohs, P., I. Podglajen, and L. Gutmann. 2004. Activities of different fluoroquinolones against Bacillus anthracis mutants selected in vitro and harboring topoisomerase mutations. Antimicrob. Agents Chemother. 48:3024-3027.
27. Horinouchi, S., and B. Weisblum. 1982. Nucleotide sequence and functional map of pC194, a plasmid that specifies inducible chloramphenicol resistance. J. Bacteriol. 150:815-825.
28. Iordanescu, S. 1995. Plasmid pT181 replication is decreased at high levels of RepC per plasmid copy. Mol. Microbiol. 16:477-484.
29. Ivanova, N., A. Sorokin, I. Anderson, N. Galleron, B. Candelon, V. Kapatral, A. Bhattacharyya, G. Reznik, N. Mikhailova, A. Lapidus, L. Chu, M. Mazur, E. Goltsman, N. Larsen, M. D'Souza, T. Walunas, Y. Grechkin, G. Pusch, R. Haselkorn, M. Fonstein, S. D. Ehrlich, R. Overbeek, and N. Kyrpides. 2003. Genome sequence of Bacillus cereus and comparative analysis with Bacillus anthracis. Nature 423:87-91.
30. Jarvest, R. L., S. A. Armstrong, J. M. Berge, P. Brown, J. S. Elder, M. J. Brown, R. C. Copley, A. K. Forrest, D. W. Hamprecht, P. J. O'Hanlon, D. J. Mitchell, S. Rittenhouse, and D. R. Witty. 2004. Definition of the heterocyclic pharmacophore of bacterial methionyl tRNA synthetase inhibitors: potent antibacterially active non-quinolone analogues. Bioorg. Med. Chem. Lett. 14:3937-3941.
31. Ji, Y., A. Marra, M. Rosenberg, and G. Woodnutt. 1999. Regulated antisense RNA eliminates alpha-toxin virulence in Staphylococcus aureus infection. J. Bacteriol. 181:6585-6590.
32. Ji, Y., G. Woodnutt, M. Rosenberg, and M. K. Burnham. 2002. Identification of essential genes in Staphylococcus aureus using inducible antisense RNA. Methods Enzymol. 358:123-128.
33. Ji, Y., D. Yin, B. Fox, D. J. Holmes, D. Payne, and M. Rosenberg. 2004. Validation of antibacterial mechanism of action using regulated antisense RNA expression in Staphylococcus aureus. FEMS Microbiol. Lett. 231:177-184.
34. Ji, Y., B. Zhang, S. F. Van, Horn, P. Warren, G. Woodnutt, M. K. Burnham, and M. Rosenberg. 2001. Identification of critical staphylococcal genes using conditional phenotypes generated by antisense RNA. Science 293:2266-2269.
35. Jones, M. E., J. Goguen, I. A. Critchley, D. C. Draghi, J. A. Karlowsky, D. F. Sahm, R. Porschen, G. Patra, and V. G. DelVecchio. 2003. Antibiotic susceptibility of isolates of Bacillus anthracis, a bacterial pathogen with the potential to be used in biowarfare. Clin. Microbiol. Infect. 9:984-986.
36. Katz, A. H., and C. E. Caufield. 2003. Structure-based design approaches to cell wall biosynthesis inhibitors. Curr. Pharm. Des. 9:857-866.
37. Kernodle, D. S., R. K. Voladri, B. E. Menzies, C. C. Hager, and K. M. Edwards. 1997. Expression of an antisense hla fragment in Staphylococcus aureus reduces alpha-toxin production in vitro and attenuates lethal activity in a murine model. Infect. Immun. 65:179-184.
38. Kraus, A., C. Hueck, D. Gartner, and W. Hillen. 1994. Catabolite repression of the Bacillus subtilis xyl operon involves a cis element functional in the context of an unrelated sequence, and glucose exerts additional xylR-dependent repression. J. Bacteriol. 176:1738-1745.
39. Li, Z., G. D. Francisco, W. Hu, P. Labthavikul, P. J. Petersen, A. Severin, G. Singh, Y. Yang, B. A. Rasmussen, Y. I. Lin, J. S. Skotnicki, and T. S. Mansour. 2003. 2-Phenyl-5,6-dihydro-2H-thieno[3,2-c]pyrazol-3-ol derivatives as new inhibitors of bacterial cell wall biosynthesis. Bioorg. Med. Chem. Lett. 13:2591-2594.
40. Macrina, F. L., J. A. Tobian, K. R. Jones, R. P. Evans, and D. B. Clewell. 1982. A cloning vector able to replicate in Escherichia coli and Streptococcus sanguis. Gene 19:345-353.
41. Marrero, R., and S. L. Welkos. 1995. The transformation frequency of plasmids into Bacillus anthracis is affected by adenine methylation. Gene 152:75-78.
42. Nakazawa, H., Y. Kikuchi, T. Honda, T. Isago, and M. Nozaki. 2003. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin. J. Infect. Chemother. 9:304-309.
43. Norrander, J., T. Kempe, and J. Messing. 1983. Construction of improved M13 vectors using oligodeoxynucleotide-directed mutagenesis. Gene 26:101-106.
44. Ochman, H., and L. M. Davalos. 2006. The nature and dynamics of bacterial genomes. Science 311:1730-1733.
45. Ochsner, U. A., C. L. Young, K. C. Stone, F. B. Dean, N. Janjic, and I. A. Critchley. 2005. Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase. Antimicrob. Agents Chemother. 49:4253-1262.
46. Odendaal, M. W., P. M. Pieterson, V. de Vos, and A. D. Botha. 1991. The antibiotic sensitivity patterns of Bacillus anthracis isolated from the Kruger National Park. Onderstepoort J. Vet. Res. 58:17-19.
47. Ondeyka, J. G., D. L. Zink, K. Young, R. Painter, S. Kodali, A. Galgoci, J. Collado, J. R. Torino, A. Basilio, F. Vicente, J. Wang, and S. B. Singh. 2006. Discovery of bacterial fatty acid synthase inhibitors from a Phoma species as antimicrobial agents using a new antisense-based strategy. J. Nat. Prod. 69:377-380.
48. Parish, T., and N. G. Stoker. 1997. Development and use of a conditional antisense mutagenesis system in mycobacteria. FEMS Microbiol. Lett. 154: 151-157.
49. Park, S., and S. H. Leppla. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr. Purif. 18:293-302.
50. Pomerantsev, A. P., N. A. Staritsin, V. Mockov Yu, and L. I. Marinin. 1997. Expression of cereolysine AB genes in Bacillus anthracis vaccine strain ensures protection against experimental hemolytic anthrax infection. Vaccine 15:1846-1850.
51. Pucci, M. J., L. F. Discotto, and T. J. Dougherty. 1992. Cloning and identification of the Escherichia coli murB DNA sequence, which encodes UDP-N-acetylenolpyruvoylglucosamine reductase. J. Bacteriol. 174:1690-1693.
52. Quinn, C. P., Y. Singh, K. R. Klimpel, and S. H. Leppla. 1991. Functional mapping of anthrax toxin lethal factor by in-frame insertion mutagenesis. J. Biol. Chem. 266:20124-20130.
53. Rasko, D. A., J. Ravel, O. A. Okstad, E. Helgason, R. Z. Cer, L. Jiang, K. A. Shores, D. E. Fouts, N. J. Tourasse, S. V. Angiuoli, J. Kolonay, W. C. Nelson, A. B. Kolsto, C. M. Fraser, and T. D. Read. 2004. The genome sequence of Bacillus cereus ATCC 10987 reveals metabolic adaptations and a large plasmid related to Bacillus anthracis pXO1. Nucleic Acids Res. 32:977-988.
54. Read, T. D., S. N. Peterson, N. Tourasse, L. W. Baillie, I. T. Paulsen, K. E. Nelson, H. Tettelin, D. E. Fouts, J. A. Eisen, S. R. Gill, E. K. Holtzapple, O. A. Okstad, E. Helgason, J. Rilstone, M. Wu, J. F. Kolonay, M. J. Beanan, R. J. Dodson, L. M. Brinkac, M. Gwinn, R. T. DeBoy, R. Madpu, S. C. Daugherty, A. S. Durkin, D. H. Haft, W. C. Nelson, J. D. Peterson, M. Pop, H. M. Khouri, D. Radune, J. L. Benton, Y. Mahamoud, L. Jiang, I. R. Hance, J. F. Weidman, K. J. Berry, R. D. Plaut, A. M. Wolf, K. L. Watkins, W. C. Nierman, A. Hazen, R. Cline, C. Redmond, J. E. Thwaite, O. White, S. L. Salzberg, B. Thomason, A. M. Friedlander, T. M. Koehler, P. C. Hanna, A. B. Kolsto, and C. M. Fraser. 2003. The genome sequence of Bacillus anthracis Ames and comparison to closely related bacteria. Nature 423: 81-86.
55. Real, G., and A. O. Henriques. 2006. Localization of the Bacillus subtilis murB gene within the dcw cluster is important for growth and sporulation. J. Bacteriol. 188:1721-1732.
56. Roberts, A. P., C. Hennequin, M. Elmore, A. Collignon, T. Karjalainen, N. Minton, and P. Mullany. 2003. Development of an integrative vector for the expression of antisense RNA in Clostridium difficile. J. Microbiol. Methods 55:617-624.
57. Rowland, S. L., J. Errington, and R. G. Wake. 1995. The Bacillus subtilis cell-division 135-137 degrees region contains an essential orf with significant similarity to murB and a dispensable sbp gene. Gene 164:113-116.
58. Sambrook, K., E. Fritsch, and T. Manialis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
59. Sobral, R. G., A. M. Ludovice, S. Gardete, K. Tabei, H. De Lencastre, and A. Tomasz. 2003. Normally functioning murF is essential for the optimal expression of methicillin resistance in Staphylococcus aureus. Microb. Drug Resist. 9:231-241.
60. Stepanov, A. V., L. I. Marinin, A. P. Pomerantsev, and N. A. Staritsin. 1996. Development of novel vaccines against anthrax in man. J. Biotechnol. 44: 155-160.
61. Sturino, J. M., and T. R. Klaenhammer. 2004. Antisense RNA targeting of primase interferes with bacteriophage replication in Streptococcus thermophilus. Appl. Environ. Microbiol. 70:1735-1743.
62. Sturino, J. M., and T. R. Klaenhammer. 2002. Expression of antisense RNA targeted against Streptococcus thermophilus bacteriophages. Appl. Environ. Microbiol. 68:588-596.
63. Tummala, S. B., S. G. Junne, and E. T. Papoutsakis. 2003. Antisense RNA downregulation of coenzyme A transferase combined with alcohol-aldehyde dehydrogenase overexpression leads to predominantly alcohologenic Clostridium acetobutylicum fermentations. J. Bacteriol. 185:3644-3653.
64. Tummala, S. B., N. E. Welker, and E. T. Papoutsakis. 2003. Design of antisense RNA constructs for downregulation of the acetone formation pathway of Clostridium acetobutylicum. J. Bacteriol. 185:1923-1934.
65. Wang, B., and H. K. Kuramitsu. 2005. Inducible antisense RNA expression in the characterization of gene functions in Streptococcus mutans. Infect. Immun. 73:3568-3576.
66. Wang, J., S. M. Soisson, K. Young, W. Shoop, S. Kodali, A. Galgoci, R. Painter, G. Parthasarathy, Y. S. Tang, R. Cummings, S. Ha, K. Dorso, M. Motyl, H. Jayasuriya, J. Ondeyka, K. Herath, C. Zhang, L. Hernandez, J. Allocco, A. Basilio, J. R. Torino, O. Genilloud, F. Vicente, F. Pelaez, L. Colwell, S. H. Lee, B. Michael, T. Felcetto, C. Gill, L. L. Silver, J. D. Hermes, K. Bartizal, J. Barrett, D. Schmatz, J. W. Becker, D. Cully, and S. B. Singh. 2006. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441:358-361.
67. Wein, L. M., D. L. Craft, and E. H. Kaplan. 2003. Emergency response to an anthrax attack. Proc. Natl. Acad. Sci. USA 100:4346-4351.
68. Xia, M., R. D. Lunsford, D. McDevitt, and S. Iordanescu. 1999. Rapid method for the identification of essential genes in Staphylococcus aureus. Plasmid 42:144-149.
69. Yang, Y., A. Severin, R. Chopra, G. Krishnamurthy, G. Singh, W. Hu, D. Keeney, K. Svenson, P. J. Petersen, P. Labthavikul, D. M. Shlaes, B. A. Rasmussen, A. A. Failli, J. S. Shumsky, K. M. Kutterer, A. Gilbert, and T. S. Mansour. 2006. 3,5-Dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria. Antimicrob. Agents Chemother. 50:556-564.
70. Yin, D., B. Fox, M. L. Lonetto, M. R. Etherton, D. J. Payne, D. J. Holmes, M. Rosenberg, and Y. Ji. 2004. Identification of antimicrobial targets using a comprehensive genomic approach. Pharmacogenomics 5:101-113.
71. Young, K., H. Jayasuriya, J. G. Ondeyka, K. Herath, C. Zhang, S. Kodali, A. Galgoci, R. Painter, V. Brown-Driver, R. Yamamoto, L. L. Silver, Y. Zheng, J. I. Ventura, J. Sigmund, S. Ha, A. Basilio, F. Vicente, J. R. Tormo, F. Pelaez, P. Youngman, D. Cully, J. F. Barrett, D. Schmatz, S. B. Singh, and J. Wang. 2006. Discovery of FabH/FabF inhibitors from natural products. Antimicrob. Agents Chemother. 50:519-526.